Advertisement
Screener

ELI LILLY AND COMPANY (LLY) Payments for (Proceeds from) Other Investing Activities

3.2 / 5 stars · 75/118 Roast Me

ELI LILLY AND COMPANY Payments for (Proceeds from) Other Investing Activities

ELI LILLY AND COMPANY (LLY) reported Payments for (Proceeds from) Other Investing Activities of $158.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-08-05

  • ELI LILLY AND COMPANY payments for (proceeds from) other investing activities for the quarter ending 2026-06-30 was $127.00M.
  • ELI LILLY AND COMPANY payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was $31.00M.
  • ELI LILLY AND COMPANY payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was -$56.80M, a 108.38% decline year-over-year.
  • ELI LILLY AND COMPANY payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was $307.80M.
  • ELI LILLY AND COMPANY payments for (proceeds from) other investing activities for fiscal 2025 was -$1.00M, a 100.40% decline from fiscal 2024.
  • ELI LILLY AND COMPANY payments for (proceeds from) other investing activities for fiscal 2024 was $248.00M, a 153.06% increase from fiscal 2023.
  • ELI LILLY AND COMPANY payments for (proceeds from) other investing activities for fiscal 2023 was $98.00M, a 67.57% decline from fiscal 2022.
  • ELI LILLY AND COMPANY payments for (proceeds from) other investing activities for fiscal 2022 was $302.20M, a 57.64% increase from fiscal 2021.
Period endPayments for (Proceeds from) Other Investing Activities 3 monthPayments for (Proceeds from) Other Investing Activities 3 month as first filedPayments for (Proceeds from) Other Investing Activities 6 monthPayments for (Proceeds from) Other Investing Activities 6 month as first filedPayments for (Proceeds from) Other Investing Activities 9 monthPayments for (Proceeds from) Other Investing Activities 9 month as first filedPayments for (Proceeds from) Other Investing Activities 12 monthPayments for (Proceeds from) Other Investing Activities 12 month as first filed
2026-06-30$127.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$158.00M
10-Q · filed 2026-08-05
$101.20M
derived: sum of 3 quarters · filed 2026-08-05
$409.00M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$31.00M
10-Q · filed 2026-04-30
-$25.80M
derived: sum of 2 quarters · filed 2026-04-30
$282.00M
derived: sum of 3 quarters · filed 2026-04-30
$141.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$56.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$251.00M
derived: sum of 2 quarters · filed 2026-02-12
$110.00M
derived: sum of 3 quarters · filed 2026-08-05
-$1.00M
10-K · filed 2026-02-12
2025-09-30$307.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$166.80M
derived: sum of 2 quarters · filed 2026-08-05
$55.80M
10-Q · filed 2025-10-30
$734.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$141.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$252.00M
10-Q · filed 2026-08-05
$24.80M
10-Q · filed 2025-08-07
$426.20M
derived: sum of 3 quarters · filed 2026-08-05
$53.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$111.00M
10-Q · filed 2026-04-30
-$39.30M
10-Q · filed 2025-05-01
$567.20M
derived: sum of 2 quarters · filed 2026-04-30
$194.00M
derived: sum of 3 quarters · filed 2026-04-30
$88.80M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$678.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$305.00M
derived: sum of 2 quarters · filed 2026-02-12
$199.80M
derived: sum of 3 quarters · filed 2026-02-12
$248.00M
10-K · filed 2026-02-12
$298.20M
10-K · filed 2025-02-19
2024-09-30-$373.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$478.40M
derived: sum of 2 quarters · filed 2025-10-30
-$430.20M
10-Q · filed 2025-10-30
$139.40M
10-Q · filed 2024-10-30
-$501.30M
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30-$105.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$57.00M
10-Q · filed 2025-08-07
-$30.40M
10-Q · filed 2024-08-08
-$128.10M
derived: sum of 3 quarters · filed 2026-02-12
$538.10M
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31$48.20M
10-Q · filed 2025-05-01
$65.20M
10-Q · filed 2024-04-30
-$22.90M
derived: sum of 2 quarters · filed 2026-02-12
$643.30M
derived: sum of 3 quarters · filed 2026-02-12
$186.50M
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31-$71.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$595.10M
derived: sum of 2 quarters · filed 2026-02-12
$138.30M
derived: sum of 3 quarters · filed 2026-02-12
$98.00M
10-K · filed 2026-02-12
$191.90M
10-K · filed 2024-02-21
2023-09-30$666.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
$209.40M
derived: sum of 2 quarters · filed 2024-10-30
$169.10M
10-Q · filed 2024-10-30
$137.20M
derived: sum of 4 quarters · filed 2025-02-19
2023-06-30-$456.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$497.10M
10-Q · filed 2024-08-08
-$529.00M
derived: sum of 3 quarters · filed 2025-02-19
-$306.20M
derived: sum of 4 quarters · filed 2025-02-19
2023-03-31-$40.30M
10-Q · filed 2024-04-30
-$72.20M
derived: sum of 2 quarters · filed 2025-02-19
$150.60M
derived: sum of 3 quarters · filed 2025-02-19
$128.50M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31-$31.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$190.90M
derived: sum of 2 quarters · filed 2025-02-19
$168.80M
derived: sum of 3 quarters · filed 2025-02-19
$302.20M
10-K · filed 2025-02-19
$206.40M
10-K · filed 2023-02-22
2022-09-30$222.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$200.70M
derived: sum of 2 quarters · filed 2023-11-02
$334.10M
10-Q · filed 2023-11-02
$268.30M
10-Q · filed 2022-11-01
$523.10M
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30-$22.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$111.30M
10-Q · filed 2023-08-08
$300.30M
derived: sum of 3 quarters · filed 2024-02-21
$353.50M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31$133.40M
10-Q · filed 2023-04-27
$322.40M
derived: sum of 2 quarters · filed 2024-02-21
$375.60M
derived: sum of 3 quarters · filed 2024-02-21
$303.20M
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$189.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
$242.20M
derived: sum of 2 quarters · filed 2024-02-21
$169.80M
derived: sum of 3 quarters · filed 2024-02-21
$191.70M
10-K · filed 2024-02-21
-$24.30M
10-K · filed 2022-02-23
2021-09-30$53.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
-$19.20M
derived: sum of 2 quarters · filed 2022-11-01
$2.70M
10-Q · filed 2022-11-01
-$83.80M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30-$72.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$50.50M
10-Q · filed 2022-08-04
-$137.00M
derived: sum of 3 quarters · filed 2023-02-22
-$149.20M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$21.90M
10-Q · filed 2022-04-29
-$64.60M
derived: sum of 2 quarters · filed 2023-02-22
-$76.80M
derived: sum of 3 quarters · filed 2023-02-22
-$29.50M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31-$86.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
-$98.70M
derived: sum of 2 quarters · filed 2023-02-22
-$51.40M
derived: sum of 3 quarters · filed 2023-02-22
-$102.80M
10-K · filed 2023-02-22
2020-09-30-$12.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27
$35.10M
derived: sum of 2 quarters · filed 2021-10-27
-$16.30M
10-Q · filed 2021-10-27
-$248.30M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30$47.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
-$4.10M
10-Q · filed 2021-08-03
-$236.10M
derived: sum of 3 quarters · filed 2022-02-23
-$94.60M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31-$51.40M
10-Q · filed 2021-04-30
-$283.40M
derived: sum of 2 quarters · filed 2022-02-23
-$141.90M
derived: sum of 3 quarters · filed 2022-02-23
-$188.30M
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31-$232.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$90.50M
derived: sum of 2 quarters · filed 2022-02-23
-$136.90M
derived: sum of 3 quarters · filed 2022-02-23
$248.70M
10-K · filed 2022-02-23
2019-09-30$141.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28
$95.10M
derived: sum of 2 quarters · filed 2020-10-28
$480.70M
10-Q · filed 2020-10-28
$479.60M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-30-$46.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$339.20M
10-Q · filed 2020-07-31
$338.10M
derived: sum of 3 quarters · filed 2021-02-17
$481.60M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-31$385.60M
10-Q · filed 2020-05-01
$384.50M
derived: sum of 2 quarters · filed 2021-02-17
$528.00M
derived: sum of 3 quarters · filed 2021-02-17
$552.10M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-31-$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
$142.40M
derived: sum of 2 quarters · filed 2021-02-17
$166.50M
derived: sum of 3 quarters · filed 2021-02-17
$187.70M
10-K · filed 2021-02-17
$191.30M
10-K · filed 2019-02-19
2018-09-30$143.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25
$167.60M
derived: sum of 2 quarters · filed 2019-10-25
$188.80M
10-Q · filed 2019-10-25
$185.90M
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30$24.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$45.30M
10-Q · filed 2019-08-02
$42.40M
derived: sum of 3 quarters · filed 2020-02-19
$103.50M
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31$21.20M
10-Q · filed 2019-05-02
$18.30M
derived: sum of 2 quarters · filed 2020-02-19
$79.40M
derived: sum of 3 quarters · filed 2020-02-19
$188.50M
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31-$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$58.20M
derived: sum of 2 quarters · filed 2020-02-19
$167.30M
derived: sum of 3 quarters · filed 2020-02-19
$175.10M
10-K · filed 2020-02-19
$215.80M
10-K · filed 2018-02-20
2017-09-30$61.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$170.20M
derived: sum of 2 quarters · filed 2018-11-06
$178.00M
10-Q · filed 2018-11-06
$233.00M
derived: sum of 4 quarters · filed 2019-10-24
2017-06-30$109.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25
$116.90M
10-Q · filed 2018-07-25
$171.90M
derived: sum of 3 quarters · filed 2019-10-24
$215.20M
derived: sum of 4 quarters · filed 2019-10-24
2017-03-31$7.80M
10-Q · filed 2018-04-27
$62.80M
derived: sum of 2 quarters · filed 2019-10-24
$106.10M
derived: sum of 3 quarters · filed 2019-10-24
$101.40M
derived: sum of 4 quarters · filed 2019-10-24
2016-12-31$55.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24
$98.30M
derived: sum of 2 quarters · filed 2019-10-24
$93.60M
derived: sum of 3 quarters · filed 2019-10-24
$130.10M
8-K · filed 2019-10-24
2016-09-30$43.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
$38.60M
derived: sum of 2 quarters · filed 2017-10-27
$75.10M
10-Q · filed 2017-10-27
$106.00M
derived: sum of 4 quarters · filed 2018-02-20
2016-06-30-$4.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28
$31.80M
10-Q · filed 2017-07-28
$62.70M
derived: sum of 3 quarters · filed 2018-02-20
$103.70M
derived: sum of 4 quarters · filed 2018-02-20
2016-03-31$36.50M
10-Q · filed 2017-05-01
$67.40M
derived: sum of 2 quarters · filed 2018-02-20
$108.40M
derived: sum of 3 quarters · filed 2018-02-20
$167.40M
derived: sum of 4 quarters · filed 2018-02-20
2015-12-31$30.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20
$71.90M
derived: sum of 2 quarters · filed 2018-02-20
$130.90M
derived: sum of 3 quarters · filed 2018-02-20
$133.60M
10-K · filed 2018-02-20
2015-09-30$41.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28
$100.00M
derived: sum of 2 quarters · filed 2016-10-28
$102.70M
10-Q · filed 2016-10-28
-$231.40M
derived: sum of 4 quarters · filed 2017-02-21
2015-06-30$59.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28
$61.70M
10-Q · filed 2016-07-28
-$272.40M
derived: sum of 3 quarters · filed 2017-02-21
-$16.60M
derived: sum of 4 quarters · filed 2017-02-21
2015-03-31$2.70M
10-Q · filed 2016-04-29
-$331.40M
derived: sum of 2 quarters · filed 2017-02-21
-$75.60M
derived: sum of 3 quarters · filed 2017-02-21
-$9.70M
derived: sum of 4 quarters · filed 2017-02-21
2014-12-31-$334.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21
-$78.30M
derived: sum of 2 quarters · filed 2017-02-21
-$12.40M
derived: sum of 3 quarters · filed 2017-02-21
$24.50M
10-K · filed 2017-02-21
2014-09-30$255.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30
$321.70M
derived: sum of 2 quarters · filed 2015-10-30
$358.60M
10-Q · filed 2015-10-30
$50.40M
10-Q · filed 2014-10-29
$364.50M
derived: sum of 4 quarters · filed 2016-02-19
2014-06-30$65.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$102.80M
10-Q · filed 2015-07-30
$31.50M
10-Q · filed 2014-07-28
$108.70M
derived: sum of 3 quarters · filed 2016-02-19
$144.50M
derived: sum of 4 quarters · filed 2016-02-19
2014-03-31$36.90M
10-Q · filed 2015-04-30
$11.90M
10-Q · filed 2014-04-28
$42.80M
derived: sum of 2 quarters · filed 2016-02-19
$78.60M
derived: sum of 3 quarters · filed 2016-02-19
$115.90M
derived: sum of 4 quarters · filed 2016-02-19
2013-12-31$5.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19
$41.70M
derived: sum of 2 quarters · filed 2016-02-19
$79.00M
derived: sum of 3 quarters · filed 2016-02-19
$97.40M
10-K · filed 2016-02-19
2013-09-30$35.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29
$73.10M
derived: sum of 2 quarters · filed 2014-10-29
$91.50M
10-Q · filed 2014-10-29
-$34.70M
derived: sum of 4 quarters · filed 2015-02-19
2013-06-30$37.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28
$55.70M
10-Q · filed 2014-07-28
-$70.50M
derived: sum of 3 quarters · filed 2015-02-19
-$52.30M
derived: sum of 4 quarters · filed 2015-02-19
2013-03-31$18.40M
10-Q · filed 2014-04-28
-$107.80M
derived: sum of 2 quarters · filed 2015-02-19
-$89.60M
derived: sum of 3 quarters · filed 2015-02-19
-$63.30M
derived: sum of 4 quarters · filed 2015-02-19
2012-12-31-$126.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19
-$108.00M
derived: sum of 2 quarters · filed 2015-02-19
-$81.70M
derived: sum of 3 quarters · filed 2015-02-19
-$64.40M
10-K · filed 2015-02-19
$100.60M
10-K · filed 2013-02-21
2012-09-30$18.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$44.50M
derived: sum of 2 quarters · filed 2013-10-30
$61.80M
10-Q · filed 2013-10-30
$140.70M
derived: sum of 4 quarters · filed 2014-02-19
2012-06-30$26.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26
$43.60M
10-Q · filed 2013-07-26
$111.50M
10-Q · filed 2012-07-27
$122.50M
derived: sum of 3 quarters · filed 2014-02-19
$124.40M
derived: sum of 4 quarters · filed 2014-02-19
2012-03-31$17.30M
10-Q · filed 2013-04-26
$50.90M
10-Q · filed 2012-04-30
$96.20M
derived: sum of 2 quarters · filed 2014-02-19
$98.10M
derived: sum of 3 quarters · filed 2014-02-19
$95.20M
derived: sum of 4 quarters · filed 2014-02-19
2011-12-31$78.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19
$80.80M
derived: sum of 2 quarters · filed 2014-02-19
$77.90M
derived: sum of 3 quarters · filed 2014-02-19
$112.20M
10-K · filed 2014-02-19
2011-09-30$1.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26
-$1.00M
derived: sum of 2 quarters · filed 2012-10-26
$33.30M
10-Q · filed 2012-10-26
$172.80M
derived: sum of 4 quarters · filed 2013-02-21
2011-06-30-$2.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27
$31.40M
10-Q · filed 2012-07-27
$170.90M
derived: sum of 3 quarters · filed 2013-02-21
$193.40M
derived: sum of 4 quarters · filed 2013-02-21
2011-03-31$34.30M
10-Q · filed 2012-04-30
$173.80M
derived: sum of 2 quarters · filed 2013-02-21
$196.30M
derived: sum of 3 quarters · filed 2013-02-21
$243.10M
derived: sum of 4 quarters · filed 2013-02-21
2010-12-31$139.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
$162.00M
derived: sum of 2 quarters · filed 2013-02-21
$208.80M
derived: sum of 3 quarters · filed 2013-02-21
$219.30M
10-K · filed 2013-02-21
2010-09-30$22.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28
$69.30M
derived: sum of 2 quarters · filed 2011-10-28
$79.80M
10-Q · filed 2011-10-28
$103.50M
derived: sum of 4 quarters · filed 2012-02-24
2010-06-30$46.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29
$57.30M
10-Q · filed 2011-07-29
$81.00M
derived: sum of 3 quarters · filed 2012-02-24
$112.70M
derived: sum of 4 quarters · filed 2012-02-24
2010-03-31$10.50M
10-Q · filed 2011-04-29
$34.20M
derived: sum of 2 quarters · filed 2012-02-24
$65.90M
derived: sum of 3 quarters · filed 2012-02-24
$86.00M
derived: sum of 4 quarters · filed 2012-02-24
2009-12-31$23.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
$55.40M
derived: sum of 2 quarters · filed 2012-02-24
$75.50M
derived: sum of 3 quarters · filed 2012-02-24
$94.50M
10-K · filed 2012-02-24
2009-09-30$31.70M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-10-29
$51.80M
derived: sum of 2 quarters · filed 2010-10-29
$70.80M
10-Q · filed 2010-10-29
-$70.80M
10-Q · filed 2009-10-30
$441.00M
derived: sum of 4 quarters · filed 2011-02-22
2009-06-30$20.10M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-02
$39.10M
10-Q/A · filed 2010-08-02
-$39.10M
10-Q · filed 2009-07-31
$409.30M
derived: sum of 3 quarters · filed 2011-02-22
$390.20M
derived: sum of 4 quarters · filed 2011-02-22
2009-03-31$19.00M
10-Q · filed 2010-07-30
$389.20M
derived: sum of 2 quarters · filed 2011-02-22
$370.10M
derived: sum of 3 quarters · filed 2011-02-22
2008-12-31$370.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22
$351.10M
derived: sum of 2 quarters · filed 2011-02-22
$284.80M
10-K · filed 2011-02-22
2008-09-30-$19.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-30
-$85.40M
10-Q · filed 2009-10-30
2008-06-30-$66.30M
10-Q · filed 2009-07-31
2007-12-31$166.30M
10-K · filed 2010-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Akari Therapeutics Plc (AKTX)$1,527.991B-47,921.42
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94